Softgel Capsules Market by Type (Gelatin, Non-Animal), Application (Cosmetics, Health Supplements, Pharmaceuticals), Distribution Channel - Global Forecast 2024-2030
The Softgel Capsules Market size was estimated at USD 4.17 billion in 2023 and expected to reach USD 4.48 billion in 2024, at a CAGR 7.71% to reach USD 7.02 billion by 2030.
Softgel capsules are a pre-formed oral dosage form composed of a gelatin-based shell surrounding a liquid or semi-solid inner fill. This type of dose form provides enhanced stability, improved accuracy in dosing, and increased bioavailability due to the protective outer shell. Softgel capsules are increasingly used in nutraceuticals due to their improved bioavailability, extended shelf life, enhanced stability of active ingredients, and cost-effectiveness compared to other dosage forms. Softgel capsules are an ideal delivery solution for targeted dosages due to their quickly dissolving capabilities, ensuring that the active ingredients are efficiently absorbed into the bloodstream for maximum effectiveness. Additionally, many consumers are adopting soft gel capsules for cosmetics and health supplements due to higher absorption rates than powders or tablets, giving them a more effective dosage of vitamins and minerals. The need for specific manufacturing equipment, fluctuating costs of raw materials, and issues in quality parameters limit their penetration worldwide. However, the ongoing advancements in manufacturing and packaging soft gel capsules with growing consumer preference for online pharmacy channels are anticipated to create growth opportunities for the soft gel capsules market in the coming years.
Regional InsightsEurope, the Middle East and the African region represents a highly developing soft gel capsules market owing to the massive presence of pharmaceutical and cosmetic product manufacturers, supportive government standards for safety and usability of healthcare capsules and ongoing advancements in processing and compositions of softgel capsules. The growing prevalence of various disorders, increasing consumer preference for beauty and healthcare supplements in the Americas has contributed to the growth of soft gel capsules. The softgel capsules market in the Asia-Pacific region observes an evolving landscape owing to rapid penetration of online channels to distribute the pharmacy and beauty supplements. The regional market players in the region are expanding their product portfolios to meet the enormous need for healthcare and cosmetic supplements.
Market InsightsMarket Dynamics
The market dynamics represent an ever-changing landscape of the Softgel Capsules Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
- Growing applications of soft gel capsules in nutraceutical industries
- Usage of softgel capsules for targeted dosages
- Rise in consumer preference for health and cosmetic supplements
Market Restraints
- High-cost of manufacturing soft gel capsules and increasing dissatisfaction in standard quality
Market Opportunities
- Technological advancements in manufacturing and packaging of softgel capsules
- Rising penetration of online pharmacy platforms worldwide
Market Challenges
- Operational and manufacturing complexities associated with soft gel capsules
Market Segmentation Analysis
- Type: of various types of softgel capsules
- Application: Wide scope of applications across industries
- Distribution Channel: Enhanced market penetration through multiple distribution channels
Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
FPNV Positioning MatrixThe FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Softgel Capsules Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share AnalysisThe market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Softgel Capsules Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent DevelopmentsLee Health Domain Launches 'D-Macula' Soft Gel Capsules in HyderabadLee Health Domain Pvt (I) Ltd., an Indian pharmaceutical company, launched its D-Macula Soft Gel Capsules in Hyderabad, India. These capsules are designed to provide essential vitamins and minerals to promote better eye health and protect against age-related macular degeneration. Additionally, the capsules are vegetarian-friendly and easy to digest for maximum absorption of nutrients.
Teva wraps up sale of India manufacturing facility to Marksans
Marksans Pharma completed its purchase of Teva Pharmaceutical Industries manufacturing facility in India. The facility gives a comprehensive range of services from Softgel capsules to tablets and liquids, allowing Marksans Pharma to expand its product lineup in both Indian and global markets. With this acquisition, Marksans Pharma increases its presence in the expanding Indian pharmaceutical market and strengthens its commitment to quality assurance across all markets.
Vitafoods Europe 2023: IFF to Launch Vegan Softgel Capsule For Nutraceuticals
IFF Inc. presented its new vegan soft gel capsule for nutraceuticals, launched at the Vitafoods Europe 2023 event. This product has been designed with enhanced bioavailability, allowing formulators to create clean-label formulations with improved absorption and efficacy. Moreover, the soft gel capsule provides a sustainable solution for those looking to maximize the value of their supplements while still preserving the environment.
Strategy Analysis & RecommendationThe strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Softgel Capsules Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company ProfilesThe report delves into recent significant developments in the Softgel Capsules Market, highlighting leading vendors and their innovative profiles. These include Aenova Group GmbH, Amway Corporation, BASF SE, Captek Softgel International Inc, Catalent, Inc., Curtis Health Caps, Delpharm, Elnova Pharma, Fortunelabs, Fuji Capsules Co Ltd., Hunan Kang Pharmaceutical Limited, InovoBiologic Inc., International Flavors & Fragrances Inc., Marksans Pharma Limited, Natural Factors, Nature's Bounty Co., Qualicaps Co., Ltd., Rocket Science Supplements Ltd., Roquette Frères, SaintyCo, Sirio Pharma Co., Ltd. by Pfizer Inc., Soft Gel Technologies, Inc., Softigel by Procaps Group, Strides Pharma Science Limited, Thermo Fisher Scientific, Inc., Trigen Laboratories Inc., United Laboratories, Weihai Baihe Biology Technological Co Ltd., and Yuwang Group.
Market Segmentation & CoverageThis research report categorizes the Softgel Capsules Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Application
- Cosmetics
- Health Supplements
- Pharmaceuticals
- Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Supermarket Stores
Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year